Cleveland biotech startup Abeona Therapeutics raises foundation-led $3.6 million

Story excerpt provided by Crain’s Cleveland Business.

Abeona Therapeutics, a Cleveland, Ohio biotechnology startup, said it has raised $3.6 million to complete preclinical development of therapies for children with Sanfilippo syndrome, a rare, terminal genetic disorder that results in death before patients reach their mid-teens.

Click here to read the complete article.

Originally published December 1, 2014.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: